# Evaluation of Electronic LogMar Visual Acuity and Contrast Sensitivity in a Population of Contact Lens Wearers

> **NCT03222037** · PHASE4 · COMPLETED · sponsor: **Johnson & Johnson Vision Care, Inc.** · enrollment: 49 (actual)

## Conditions studied

- Visual Acuity

## Interventions

- **DEVICE:** senofilcon A
- **DEVICE:** Control

## Key facts

- **NCT ID:** NCT03222037
- **Lead sponsor:** Johnson & Johnson Vision Care, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-27
- **Primary completion:** 2017-08-04
- **Final completion:** 2017-08-04
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2019-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03222037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03222037, "Evaluation of Electronic LogMar Visual Acuity and Contrast Sensitivity in a Population of Contact Lens Wearers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03222037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*